Progressive Platelet Rich Fibrin tissue regeneration matrix: Description of a novel, low cost and effective method for the treatment of chronic diabetic ulcers—Pilot study
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0284701 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Carlos José Saboia-Dantas und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Pesquisa em Reparo Tecidual, Universidade Federal de Uberlândia, Uberlândia, Minas Gerais, Brasil. Hauptthemen laut MEDLINE: Platelet-Rich Fibrin, Leg Ulcer, Stomach Ulcer, Vascular Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Chronic lower limb ulcers (CLLU) are those injuries that persist for more than six weeks despite adequate care. They are relatively common; it is estimated that 10/1,000 people will develop CLLU in their lifetime. Diabetic ulcer, because of its unique pathophysiology (association between neuropathy, microangiopathy, and immune deficiency), is considered one of the most complex and difficult etiologies of CLLU for treatment. This treatment is complex, costly, and sometimes frustrating, as it is often ineffective, which worsens the quality of life of patients and makes its treatment a challenge.
Objective
To describe a new method for treating diabetic CLLU and the initial results of using a new autologous tissue regeneration matrix.
Method
This is a pilot, prospective, an interventional study that used a novel protocol of autologous tissue regeneration matrix for the treatment of diabetic CLLU.
Results
Three male cases with a mean age of 54 years were included. A total of six Giant Pro PRF Membrane (GMPro) were used varying their application between one to three sessions during treatment. A total of 11 liquid phase infiltrations were performed varying their application between three and four sessions. The patients were evaluated weekly and a reduction in the wound area and scar retraction was observed during the period studied.
Conclusion
The new tissue regeneration matrix described is an effective and low-cost method for the treatment of chronic diabetic ulcers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Laboratorio de Pesquisa em Reparo Tecidual, Universidade Federal de Uberlândia, Uberlândia, Minas Gerais, Brasil.
- Instituto de Tecnologia e Ensino em Cirurgias, Uberlândia, Minas Gerais, Brazil.
- Departamento de Cirurgia, Centro Universitário FMABC, Santo André, São Paulo, Brasil.
- Laboratório de Delineamento de Pesquisas e Escrita Científica, Centro Universitário FMABC, Santo André, São Paulo, Brasil.
ORCID-Profile: Carlos José Saboia-Dantas, Rodrigo Daminello Raimundo
Zitieren
APA
Saboia-Dantas, C. J., Dechichi, P., Fech, R. L., de Carvalho Furst, R. V., Raimundo, R. D., & Correa, J. A. (2023). Progressive Platelet Rich Fibrin tissue regeneration matrix: Description of a novel, low cost and effective method for the treatment of chronic diabetic ulcers—Pilot study. PLOS ONE. https://doi.org/10.1371/journal.pone.0284701
Vancouver
Saboia-Dantas CJ, Dechichi P, Fech RL, de Carvalho Furst RV, Raimundo RD, Correa JA. Progressive Platelet Rich Fibrin tissue regeneration matrix: Description of a novel, low cost and effective method for the treatment of chronic diabetic ulcers—Pilot study. PLOS ONE. 2023. doi:10.1371/journal.pone.0284701
BibTeX
@article{SaboiaDantas2023,
author = {Saboia-Dantas, Carlos José and Dechichi, Paula and Fech, Roberto Lichtsztejn and de Carvalho Furst, Rafael Vilhena and Raimundo, Rodrigo Daminello and Correa, João Antonio},
title = {Progressive Platelet Rich Fibrin tissue regeneration matrix: Description of a novel, low cost and effective method for the treatment of chronic diabetic ulcers—Pilot study},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0284701}
}
EUVIMED